The gp130-stimulating designer cytokine hyper-IL-6 promotes the expansion of human hematopoietic progenitor cells capable to differentiate into functional dendritic cells

Experimental Hematology

Volumn 28, Issue 4, 2000, Pages 365-372

  Bernhard, Helga ^a   Lohmann, Matthias ^b   Batten, Wendy Y ^b   Metzger, Jochen ^a   Löhr, Hanns F ^b   Peschel, Christian ^a   Zum Büschenfelde, Karl Hermann Meyer ^b   Rose John, Stefan ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigen presentation; Cytokines; Dendritic cells; Hematopoiesis; Hyper IL 6; T cells

Indexed keywords

CD34 ANTIGEN; CD83 ANTIGEN; GLYCOPROTEIN GP 130; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B CORE ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN F2; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; FLOW CYTOMETRY; HELPER CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; DENDRITIC CELLS; DINOPROSTONE; FLOW CYTOMETRY; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HEMATOPOIETIC STEM CELLS; HEPATITIS B CORE ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; OXYTOCICS; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; STEM CELL FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034104468     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00126-0     Document Type: Article

References (37)

1. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors. generation and biological function Biochem J. 300:1994;281.
2. Peters M., Müller A.M., Rose-John S. Interleukin-6 and soluble interleukin-6 receptor. direct stimulation of gp130 and hematopoiesis Blood. 92:1998;3495.
3. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1990;1149.
4. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315.
5. Schirmacher P., Peters M., Ciliberto G., Fattori F., Lotz J., Meyer zum Büschenfelde K.-H., Rose-John S. Hepatocellular hyperplasia, plasmacytoma formation, and extracellular hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Am J Pathol. 153:1998;639.
6. Peters M., Schirrmacher P., Goldschmitt J., Odenthal M., Peschel C., Fattori E., Ciliberto G., Dienes H.-P., Meyer zum Büschenfelde K.-H., Rose-John S. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med. 185:1997;755.
7. Sui X., Tsuj K., Tanaka R., Tajima S., Muraoka K., Ebihara Y., Ikebuchi K., Yasukawa K., Taga T., Kishimoto T., Nakahata T. Gp130 and c-kit signalings synergize for ex vivo expansion of human primitive progenitor cells. Proc Natl Acad Sci U S A. 92:1995;2859.
8. Tajima S., Tsuji K., Ebihara Y., Sui X., Tanaka R., Muraoka K., Yoshida M., Yamada K., Yasukawa K., Taga T., Kishimoto T., Nakahata T. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J Exp Med. 184:1996;1357.
9. Wells J.A. Binding in the growth hormone receptor complex. Proc Natl Acad Sci U S A. 93:1996;1.
10. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P., Kallen K.J., Wollmer A., Grötzinger J., Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol. 15:1997;142.
11. Peters M., Blinn G., Solem F., Fischer M., Meyer zum Büschenfelde K.-H., Rose-John S. In vivo and in vitro activities of the gp130-stimulating designer cytokine hyper-IL-6. J Immunol. 161:1998;3575.
12. Reid C.D., Fryer P.R., Clifford C., Kirk A., Tikerpae J., Knight S.C. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood. 76:1990;1139.
13. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNFalpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258.
14. Bernhard H., Disis M.L., Heimfeld S., Hand S., Gralow J.R., Cheever M.A. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1995;1099.
15. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingston A.M., Fathman C.G., Inaba K., Steinman R.M. Presentation of exogenous protein antigens by dendritic cells to T cell clones. intact protein is presented best by immature, epidermal Langerhans cells J Exp Med. 169:1989;1169.
16. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109.
17. Albert M.L., Pearce S.F.A., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 7:1998;1359.
18. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245.
19. Bernhard H., Karbach J., Wölfel T., Busch P., Störkel S., Stöckle M., Wölfel C., Seliger B., Huber C., Meyer zum Büschenfelde K.-H., Knuth A. Cellular immune response to human renal cell carcinomas. definition of a common antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes (CTL) clones Int J Cancer. 59:1994;1.
20. Heike M., Schlaak J., Schulze-Bergkamen H., Heyl S., Herr W., Schmitt U., Schneider P.M., Meyer zum Büschenfelde K.-H. Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma. evidence for several recognized antigens J Immunol. 156:1996;2205.
21. Jonuleit H., Kuhn U., Müller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 27:1997;3135.
22. Pickl W.F., Majdic O., Kohl P., Stöckl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 157:1997;3850.
23. Oehler L., Majdic O., Pickl W.F., Stöckl J., Riedl E., Drach J., Rappersberger K., Geissler K., Knapp W. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med. 187:1998;1019.
24. Galy A., Travis M., Cen D., Cen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:1995;459.
25. Saunders D., Lucas K., Ismaili J., Wu L., Maraskovsky E., Dunn A., Shortman K. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Med. 184:1996;2185.
26. Kitajama T., Caceres-Dittmar G., Tapia F.J., Jester J., Bergstresser P.R., Takashima A. T cell-mediated terminal maturation of dendritic cells. J Immunol. 157:1996;2340.
27. Bernhard H., Huseby E.S., Hand S.L., Lohmann M., Batten W.Y., Disis M.L., Gralow J.R., Meyer zum Büschenfelde K.-H. Dendritic cells lose ability to present protein antigen after antigen-specific T cell responses, despite upregulation of MHC class II expression. Immunobiol. 201:2000;568.
28. + T lymphocytes by human blood dendritic cells in vitro. J Clin Invest. 90:1992;229.
29. Caux C., Vanbervliet B., Massacrier C., Azuma M., Okumura K., Lanier L.L., Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 180:1994;1841.
30. Zhou L.-J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 154:1995;3821.
31. Zandstra P.W., Conneally E., Piret J.M., Eaves C.J. Ontogeny-associated changes in the cytokine responses of primitive human haemapoietic cells. Br J Haematol. 101:1998;770.
32. Ebihara Y., Tsuji K., Lyman S.D., Sui X., Yoshida M., Muraoka K., Yamada K., Tanaka R., Nakahata T. Synergistic action of FLT3 and gp130 signalings in human hematopoiesis. Blood. 90:1997;4363.
33. Löhr H.F., Weber W., Schlaak J., Goergen B., Meyer zum Büschenfelde K.-H., Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology. 22:1995;61.
34. 2-microglobulin. Eur J Immunol. 27:1997;3471.
35. Wild J., Grusby M.J., Schirmbeck R., Reimann J. Priming MHC-I-restricted cytotoxic T lymphocyte response to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol. 163:1999;1880.
36. Ridge J.P., DiRosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 303:1998;474.
37. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:1996;52.